1. Home
  2. DOGZ vs CNTB Comparison

DOGZ vs CNTB Comparison

Compare DOGZ & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DOGZ

Dogness (International) Corporation

HOLD

Current Price

$11.40

Market Cap

153.5M

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.51

Market Cap

128.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOGZ
CNTB
Founded
2003
2012
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
128.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
DOGZ
CNTB
Price
$11.40
$2.51
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
796.3K
87.3K
Earning Date
03-16-2026
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,707,707.00
$762,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24,739.01
P/E Ratio
N/A
N/A
Revenue Growth
39.47
N/A
52 Week Low
$6.81
$0.51
52 Week High
$38.00
$3.28

Technical Indicators

Market Signals
Indicator
DOGZ
CNTB
Relative Strength Index (RSI) 57.93 55.40
Support Level $11.00 $2.10
Resistance Level $12.80 $2.88
Average True Range (ATR) 0.55 0.23
MACD 0.08 0.03
Stochastic Oscillator 40.87 60.44

Price Performance

Historical Comparison
DOGZ
CNTB

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Share on Social Networks: